United States · Funded startup

Who invested in EarliTec Diagnostics

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Consumer Services

Raised 7 months ago

Funding summaryUpdated 15 Nov 2026

$3.5Mraised across 1 round since 2026, from 1 source

Latest round
Round, $3.5MApr 2026
Investors
0
See who backed them

The rounds

  1. Apr 2026
    Round$3.5M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $3.5M sold, first sale Apr 2026

Funding filed with regulators

EarliTec Diagnostics filed 3 raises, $30M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Apr 2026$3.5M3 investorsof $7.0M offeredSEC Form D
  2. Mar 2024$21M5 investorsequityof $36M offeredSEC Form D
  3. Feb 2022$5.5M3 investorsequityof $20M offeredSEC Form D

Founders and team

From EarliTec Diagnostics's own website: 8 on the team.

  • Christopher MacAloonExecutive Vice President of Operations
  • Jamie PagliaroPresident & CEO
  • Leota PearsonChief Financial Officer
  • Pete PolgarVP of Marketing
  • Ella Swanson-HysellDirector Of Product Management & Innovation
  • Kurt JacobusChairman of the Board
  • Mike VassarDirector of Sales
  • Ryan BormannDirector Of Operations And Quality

Quick answers about EarliTec Diagnostics

How much has EarliTec Diagnostics raised?

EarliTec Diagnostics has raised $3.5M across 1 round since 2026.

When did EarliTec Diagnostics last raise?

EarliTec Diagnostics's most recent round, $3.5M, was in Apr 2026.

What was EarliTec Diagnostics's biggest round?

Its most recent round, $3.5M in Apr 2026, is also its largest on record.

Where is EarliTec Diagnostics based?

EarliTec Diagnostics is based in the United States.

Companies like EarliTec Diagnostics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.